Breast Carcinoma
Conditions
Brief summary
This clinical trial studies how well a virtual support platform, the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) application (app), works in improving survivorship among Black survivors of breast cancer. The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment. This trial may help improve how digital health interventions can enhance survivorship support and access to resources.
Interventions
OTHERDiscussion
Ancillary studies
OTHERInternet-Based Intervention
Use the HERCaRE app
OTHERInterview
Ancillary studies
OTHERSurvey Administration
Ancillary studies
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults aged 18 and older * Self-identified Black women with a history of breast cancer * "Self-identified Black woman" refers to individuals who personally identify as a Black or African American woman, inclusive of cisgender women from diverse cultural backgrounds. This will be confirmed during a verbal eligibility screening conducted prior to enrollment * Completed active breast cancer treatment (e.g., surgery, chemotherapy, or radiation) at least one month prior to enrollment; survivors receiving long-term hormonal therapy are also eligible * Reside within the Mayo Clinic Florida catchment area * Have access to a smartphone or willingness to use alternative access points * "Alternative access points" refer to non-clinical settings through which participants may be made aware of the study, including support groups, community health events, churches, and partner organizations that engage with breast cancer survivors outside of the traditional healthcare setting
Exclusion criteria
* Individuals without a history of breast cancer * Those unable to provide verbal consent * Individuals who lack the ability to engage with digital platforms, as determined during the screening process via brief questions assessing comfort and experience with mobile technology. Participants must be able to open the app, read content, and complete survey independently. iPads will be available for participants who do not have their own mobile device
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survivorship engagement - login | Up to 6 weeks | Assessed by active use of the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) platform, defined as number of logins per participant. |
| Survivorship engagement - time | Up to 6 weeks | Assessed by the length of time each participant spent using the HERCaRE platform. |
| Survivorship engagement - self-report | Up to 6 weeks | Assessed by self-reported actions such as initiating conversations with providers or accessing survivorship resources. Information will be obtained through semi-structured interviews. |
| Adherence to follow-up care | Up to 6 weeks | Assessed by participant self-reported scheduling or completion of appointments (e.g., mammograms, primary care physician visits). Information will be obtained through semi-structured interviews. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Participant satisfaction - HERCaRE Final Survey | Up to 6 weeks | Will be assessed by 5 question from a 9-question HERCaRE Final Survey. Three questions are answered on a 5-point scale (strongly agree, agree, neutral, disagree, strongly disagree), and two questions are open-ended/free text. |
| Perceived usability - HERCaRE Final Survey | Up to 6 weeks | Will be assessed by a 4 question of a 9-question HERCaRE Final Survey. Two questions are multiple choice (e.g., Yes, No, Not sure) Once is related to likelihood of taking follow-up actions such as "schedule and attend a follow-up appointment" or "ask more questions during my next visit." The final question is an open-ended/free text question related to any difficulties using the app or competing activities. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORManisha Salinas, DrPH
Mayo Clinic
Outcome results
None listed